Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”

New treatment options especially of solid tumors including for metastasized prostate cancer (PCa) are urgently needed. Recent treatments of leukemias with chimeric antigen receptors (CARs) underline their impressive therapeutic potential. However CARs currently applied in the clinics cannot be repea...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Feldmann, Anja, Arndt, Claudia, Bergmann, Ralf, Loff, Simon, Cartellieri, Marc, Bachmann, Dominik, Aliperta, Roberta, Hetzenecker, Mirjam, Ludwig, Florian, Albert, Susann, Ziller-Walter, Pauline, Kegler, Alexandra, Koristka, Stefanie, Gärtner, Sebastian, Schmitz, Marc, Ehninger, Armin, Ehninger, Gerhard, Pietzsch, Jens, Steinbach, Jörg, Bachmann, Michael
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2017
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458214/
https://ncbi.nlm.nih.gov/pubmed/28404896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15572
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk